At a glance
ClinicalIndex Comparison RecordN/ACompleted· 117 enrolled
Drug / intervention
MRZF111device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multicenter, Parallel-group, Evaluator-blind, Randomized Study to Investigate the Effectiveness and Safety of MRZF111 in the Treatment of décolleté Wrinkles
In Brief
A clinical study evaluating MRZF111 for Décolleté Wrinkles. Completed, enrolled 117 participants across 9 sites.
Detailed Summary
To evaluate the effectiveness and safety of MRZF111 treatment for improvement of décolleté wrinkles as assessed on the Merz Aesthetics Scales (MAS) Décolleté Wrinkles-At Rest.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDécolleté Wrinkles
CountriesGermany
CollaboratorsMerz Pharmaceuticals GmbH
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartDec 2019
Primary CompletionNov 2020
Study CompletionFeb 2021
TodayJul 2026
First PostedNov 26, 2019
Enrollment StartDec 4, 2019
Primary CompletionNov 17, 2020
Study CompletionFeb 23, 2021
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.6 years ago
Interventions
MRZF111device
MRZF111 kit consisting of one syringe of RADIESSE® Volume injectable implant, injection needles and additional components. Physiological saline solution (0.9% NaCl) is used to dilute Radiesse Volume by 1:2. Radiesse consists of calcium hydroxylapatite particles suspended in an aqueous-based gel carrier.